PoshanSense
Digestive comfort · 5 min read

Does a low-FODMAP diet help IBS and bloating?

Low-FODMAP diets can help some people with IBS, but more restriction is not always better. UK and Thai trials explain a practical, temporary approach.

A colourful bowl of fruit and vegetables beside an open blank journal in a bright kitchen.
Original conceptual illustration; food tolerance is individual, not a universal good-food/bad-food list.

Complementary human studies · Published 2020–2022

If your stomach feels unpredictable, a diet with a clear list of things to avoid can sound wonderfully reassuring. But the goal of a low-FODMAP approach is not to build the longest possible forbidden-food list. It is to discover whether particular fermentable carbohydrates contribute to your symptoms, then keep as much variety as you comfortably can.

That distinction changes the question from “Is this food bad?” to “Does this amount, in this meal, cause a problem for me?” Foods that bother one person can be perfectly ordinary choices for another. IBS also involves more than food alone.

What are FODMAPs, in everyday language?

FODMAP is an umbrella term for several carbohydrates that can be incompletely absorbed and fermented in the gut. Depending on the food and amount, they occur in foods as different as wheat, milk, some fruits, legumes and certain sweeteners. They are not all sugar, and they are not the same thing as gluten.

The resulting water and gas can matter particularly in a sensitive gut. That does not make fermentation harmful for everyone, or establish that a single episode of bloating means IBS. Diagnosis matters before a person starts removing several nutritious food groups.

Does stricter advice work better?

A UK trial comparing three approaches offers a useful reality check. After four weeks, 55% of the analysed low-FODMAP group met the response threshold, compared with 42% following traditional advice and 58% following gluten-free advice. These differences were not statistically clear.

That does not prove the diets identical: the trial was relatively small. It does show why “the strictest diet is always the best” goes beyond the evidence. Participants found traditional advice cheaper, easier to shop for and easier to follow when eating out.

Why another trial found a bigger difference

In a Thai trial, 66 people were randomized and 62 contributed the final analysis. Individual advice based on their food diaries produced more pain/discomfort responders than brief general advice: 60% versus 28% after four weeks.

However, the individual session could last about 30 minutes; the general session lasted five. Attention, specificity and practical support differed alongside the dietary strategy. The study supports personalised help with familiar meals, rather than proving that a generic internet restriction list delivers the same benefit.

The trials also used different symptom thresholds and included different IBS types. Their percentages should not be lined up as though they were two competing product ratings. Both help answer the practical question: guidance and the comparison diet matter.

Original explanatory infographic

The destination is a broader diet you tolerate

01

Understand the problem

IBS symptoms and occasional bloating are not the same diagnosis.

02

Try a focused approach

Compare simpler advice and a supervised short restriction trial.

03

Reintroduce

Test tolerance rather than turning initial exclusions into lifetime rules.

04

Personalise

Keep useful foods and avoid more restriction than you need.

A conceptual pathway, not a self-directed elimination prescription or a guaranteed response.

What this means for your own kitchen

A curry, pasta sauce or shared family meal contains several ingredients. Removing the entire dish can unnecessarily narrow your choices. A dietitian can help identify relevant ingredients, quantities and substitutions without treating every regional cuisine as a problem.

The Thai researchers worked from patients’ actual food diaries and locally available alternatives. That principle travels well: an approach should fit foods you eat and can afford. The exact ingredients and serving sizes still need personal assessment; a trial in Bangkok does not supply a universal menu for Mumbai, Manchester or Chicago.

There is also a practical difference between reducing something and replacing it. If a restriction removes a regular source of fibre or calcium, the replacement deserves attention. The Thai trial did not establish long-term nutritional safety, and the UK trial examined only four weeks.

Restriction is the opening chapter, not the ending

Monash University describes three stages: an initial low-FODMAP period, reintroduction, then personalisation. The aim is to learn your tolerance and expand the diet. Staying indefinitely in the strict initial stage misses that purpose.

If symptoms persist or are new, do not keep escalating restrictions as a substitute for assessment. Other conditions can produce similar complaints. A clinician can establish what is being investigated, and a suitably trained dietitian can decide whether this approach is appropriate.

For someone already diagnosed with IBS, a useful conversation is: Which simpler changes have I tried? How will we judge whether a trial helps? When and how will foods return? These questions create a clearer finish line than “I will avoid more things until my gut is perfect.”

How much confidence should you place in the evidence?

The UK study was funded by a gluten-free food manufacturer, with an educational-grant disclosure; the authors reported no funder role in the study. The Thai study had university and gastroenterology-association support and declared no conflicts. Both were short, and people knew which advice they received. Their findings support a thoughtful option for IBS, not a guarantee for every bloated stomach.

Sources & further reading

  1. United Kingdom · three dietary approaches (2022)
  2. Thai personalised low-FODMAP advice trial
  3. UK full primary paper and supplementary material
  4. Monash University three-step approach

Study years differ from this article’s publication date. We reviewed full primary papers and relevant supporting material; access limitations are kept out of efficacy claims. Original illustrations and diagrams; no publisher figures reproduced. Educational writing, not clinical review.

Published 11 October 2026 · Sources checked 11 October 2026. Suggest a correction.